Frontlight ResearchEarly access
Neuroendocrine tumours trials in Greece
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Athens, Thessaloniki
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 - No phaseTaking peopleGenomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
- Where
- Athens
- Age
- 18 years to 85 years
- People
- 111 worldwide
- Run by
- Oncology Center of Biochemical Education And Research
See details and how to joinNCT06717243